Pilz, L. R., Manegold, C., & Schmid-Bindert, G. (2012). Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? Transl Lung Cancer Res.
Citação norma ChicagoPilz, Lothar R., Christian Manegold, and Gerald Schmid-Bindert. "Statistical Considerations and Endpoints for Clinical Lung Cancer Studies: Can Progression Free Survival (PFS) Substitute Overall Survival (OS) As a Valid Endpoint in Clinical Trials for Advanced Non-small-cell Lung Cancer?" Transl Lung Cancer Res 2012.
Citação norma MLAPilz, Lothar R., Christian Manegold, and Gerald Schmid-Bindert. "Statistical Considerations and Endpoints for Clinical Lung Cancer Studies: Can Progression Free Survival (PFS) Substitute Overall Survival (OS) As a Valid Endpoint in Clinical Trials for Advanced Non-small-cell Lung Cancer?" Transl Lung Cancer Res 2012.